From absorbance to percent released: volume correction for withdrawn samples and the USP <711> stage logic, worked through one run.
August 11, 2026
Insights
Articles for analytical, QC and CMC teams: spectra, impurities, stability, ICH M7 and HPLC, each with a worked example.

Guide8 min read
From absorbance to percent released: volume correction for withdrawn samples and the USP <711> stage logic, worked through one run.
August 11, 2026
Guide8 min read
A response surface methodology tutorial with a worked example: 18-run CCD, quadratic fit R2 0.9988, optimum with CIs, design space and residual.
August 10, 2026
Use case8 min read
High concentration antibody viscosity decides whether your mAb can be a subcutaneous injection. Predict it from sequence before formulation work begins.
August 8, 2026
Guide15 min read
HPLC column selection chart and decision tree: match C18, phenyl-hexyl, PFP, HILIC or mixed-mode to logD and pKa. Scout fewer columns, start here.
August 7, 2026
Explainer7 min read
ICH M7 classification explained class by class, with the dual (Q)SAR assessment and five real impurities scored, including NDMA.
August 6, 2026
Explainer8 min read
pLDDT interpretation for practitioners: what the bands mean, why a global mean hides the region you care about, and real numbers on MSA depth.
August 6, 2026
Guide8 min read
ADC design from sequence: DAR distribution, conjugation site counts, linker stability and the hydrophobicity/aggregation trade-off, with real data.
August 4, 2026
Guide9 min read
UV dissolution testing end to end: calibration, ICH Q2(R2) validation, f1/f2 similarity, sink conditions, and where UV loses to HPLC, with a worked example.
August 2, 2026
Use case8 min read
A QbD process development workflow end to end: DoE screen, response surface, regression on one 29-run Pd coupling, with every number really calculated.
July 31, 2026
Explainer8 min read
Docking score interpretation, honestly: what a −10 kcal/mol docking score does and does not tell you, using a real docking run on KRAS G12C.
July 31, 2026
Use case8 min read
LNP formulation optimization for mRNA with real results: MC3 baseline 86.3% EE, 94.9 nm, PDI 0.150, and a Pareto front reaching 88.0%.
July 30, 2026
Use case7 min read
Ionizable lipid screening without burning stock: rank custom lipids from SMILES, pick the most informative next run, and see the real size trade-off.
July 27, 2026
Next step
30 minutes on Microsoft Teams with the CovaSyn team. If it is not a fit, we will say so.